A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

NCT04237805 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Advanced Solid Tumor
Lung Cancer, Nonsmall Cell

Interventions

DRUG: SAF-189s

Sponsor

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.